The Vox Markets Podcast

hVIVO has been selected to run the world’s first pivotal Phase III human challenge trial in whooping cough, marking a major scientific milestone and its largest study to date. The contract strengthens revenue visibility into 2026–27 while underlining the growing importance of human challenge trials in accelerating vaccine approvals globally.

Watch on YouTube 

Rift Helium has listed on Aim and raised £8 million in the process. Some serious backers are behind the company, including RAB Capital and Miton, and lists amongst its senior advisors well-known names in helium Neil Herbert and Tom Abraham-James. The company plans to embark on a major programme of 3-D seismic this year, and will likely drill two wells in 2027, although the details of the drilling will be determined by the results of the seismic. Rift is entering an area in which other helium companies are already operating, and will be able to deploy some of the knowledge gleaned by those first movers. Charlie Fitzroy, the company's chief executive joins Vox to tell us more.

Watch on YouTube

Tooru has agreed terms in principle to acquire fast-growing plant-based e-commerce brand Mylky for £12 million, in a deal that could materially expand its “free from” platform. In this interview, management discusses the strategic fit, the quality of Mylky’s earnings, how the transaction will be financed, and what investors should watch as due diligence, funding and shareholder approval still need to be secured.

Watch on YouTube

In this positive interview, CEO Adam Holland & CFO Will Wilkins of MPAC take me through today’s resilient 2025 results and in line guidance, despite the challenging macro backdrop. 00:00 FY'25 order intake and current Q1 demand 05:15 Financial highlights 08:40 Consolidation and integration of acquisitions 12:30 FY’26 outlook and new interim CFO 14:30 Closing remarks

Watch on YouTube
ECR is acquiring Paleogold Ltd, an Australian gold company with several significant gold assets. It takes the total number of assets in the ECR portfolio to ten, and means that by the end of the year the company will likely be running three separate gold producing operations. The latest deal is being funded by a complex combination of shares, cash, and convertible notes, but nearly all of the payment is deferred. The idea is that these new operations will end up paying for themselves. Nick Tulloch, ECR's chairman joins Vox to explain how it all fits together.